211 related articles for article (PubMed ID: 6508979)
1. Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.
Teunissen MW; Bakker W; Meerburg-Van der Torren JE; Breimer DD
Br J Clin Pharmacol; 1984 Nov; 18(5):701-6. PubMed ID: 6508979
[TBL] [Abstract][Full Text] [Related]
2. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
Breimer DD; Zilly W; Richter E
Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
[TBL] [Abstract][Full Text] [Related]
3. Differential induction of antipyrine metabolism by rifampicin.
Toverud EL; Boobis AR; Brodie MJ; Murray S; Bennett PN; Whitmarsh V; Davies DS
Eur J Clin Pharmacol; 1981; 21(2):155-60. PubMed ID: 7341283
[TBL] [Abstract][Full Text] [Related]
4. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
van den Broek JM; Teunissen MW; Breimer DD
Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
[TBL] [Abstract][Full Text] [Related]
5. The effect of antipyrine and rifampin on the metabolism of diazepam.
Ohnhaus EE; Brockmeyer N; Dylewicz P; Habicht H
Clin Pharmacol Ther; 1987 Aug; 42(2):148-56. PubMed ID: 3608348
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of enzyme induction on antipyrine metabolite formation.
Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of rifabutin and rifampicin on hepatic microsomal enzyme activity in normal subjects.
Perucca E; Grimaldi R; Frigo GM; Sardi A; Mönig H; Ohnhaus EE
Eur J Clin Pharmacol; 1988; 34(6):595-9. PubMed ID: 2901960
[TBL] [Abstract][Full Text] [Related]
8. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
9. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
[TBL] [Abstract][Full Text] [Related]
10. Effect of chloroquine and primaquine on antipyrine metabolism.
Back DJ; Purba HS; Park BK; Ward SA; Orme ML
Br J Clin Pharmacol; 1983 Nov; 16(5):497-502. PubMed ID: 6639836
[TBL] [Abstract][Full Text] [Related]
11. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
[TBL] [Abstract][Full Text] [Related]
12. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of induction by rifampin of alpha 1-acid glycoprotein and antipyrine clearance in the dog.
Abramson FP; Lutz MP
Drug Metab Dispos; 1986; 14(1):46-51. PubMed ID: 2868864
[TBL] [Abstract][Full Text] [Related]
14. The effect of fenfluramine on disposition and rate of antipyrine elimination.
O'Malley K; Stevenson IH; West M
Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
[TBL] [Abstract][Full Text] [Related]
15. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of aldosterone in patients with Addison's disease: effect of rifampicin treatment on glucocorticoid and mineralocorticoid metabolism.
Schulte HM; Mönig H; Benker G; Pagel H; Reinwein D; Ohnhaus EE
Clin Endocrinol (Oxf); 1987 Dec; 27(6):655-62. PubMed ID: 3455371
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of antipyrine and sulphadimidine in dwarf goats: effects of the enzyme-inducing agents phenobarbital, troleandomycin and rifampicin.
Natsuhori M; Witkamp RF; Van 't Klooster GA; Van Miert AS
Xenobiotica; 1992 Nov; 22(11):1243-50. PubMed ID: 1492417
[TBL] [Abstract][Full Text] [Related]
18. [Isoniazid and rifampicin in the rabbit. Effect on hepatic microsomal enzyme activity].
Kergueris MF; Larousse C; Le Normand Y; Guillerme G; Bourin M
J Pharmacol; 1982; 13(4):525-34. PubMed ID: 7154665
[TBL] [Abstract][Full Text] [Related]
19. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL
Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis therapy and enzyme induction in man.
Larousse C; Le Normand Y; Kergueris MF; Veyrac MJ; Chailleux E; Ordronneau J; Moigneteau C
Int J Clin Pharmacol Ther Toxicol; 1980 Apr; 18(4):163-8. PubMed ID: 7380590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
